Document and Entity Information
Document and Entity Information | Mar. 17, 2022 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Mar. 17, 2022 |
Entity Registrant Name | Chinook Therapeutics, Inc. |
Entity Central Index Key | 0001435049 |
Entity Emerging Growth Company | false |
Entity File Number | 001-37345 |
Entity Incorporation State Country Code | DE |
Entity Tax Identification Number | 94-3348934 |
Entity Address, Address Line One | 400 Fairview Avenue North |
Entity Address, Address Line Two | Suite 900 |
Entity Address, City or Town | Seattle |
Entity Address, State or Province | WA |
Entity Address, Postal Zip Code | 98109 |
City Area Code | (206) |
Local Phone Number | 485-7241 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, par value $0.0001 per share |
Trading Symbol | KDNY |
Security Exchange Name | NASDAQ |